Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Aneurysm II: Clinical Manifestations and Diagnostic Studies01:21

Aneurysm II: Clinical Manifestations and Diagnostic Studies

391
Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
391
Aneurysm I: Introduction01:30

Aneurysm I: Introduction

449
An aortic aneurysm is a localized outpouching or dilation at a weak point in the artery wall. It may involve different parts of the aorta, such as the abdominal aorta, aortic arch, or thoracic aorta.Etiological factorsSeveral disorders are associated with aortic aneurysms.Congenital causes, such as primary connective tissue disorders like Marfan syndrome, impact the integrity and strength of connective tissues, notably affecting the aorta. Marfan syndrome is a genetic disorder that specifically...
449
Aortic Regurgitation I: Introduction01:15

Aortic Regurgitation I: Introduction

756
IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
756
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

604
Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
604
Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

326
Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
326
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

571
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
571

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Thromboexclusion Procedure for a Recurrent Descending Aortic Pseudoaneurysm in the Pre-Stent Era.

Annals of thoracic surgery short reports·2026
Same author

Thoracic Aortic Aneurysm and Giant Cell Arteritis: Clarifying the Link.

Aorta (Stamford, Conn.)·2025
Same author

Novel Aortic Root Measurement Technique Using the Laplace Diameter for Identifying Patients at Risk for Type A Dissection.

Annals of thoracic surgery short reports·2025
Same author

A normal BNP does not reliably exclude pulmonary hypertension in interstitial lung disease.

The European respiratory journal·2025
Same author

Thoracic aortic aneurysm.

Nature reviews. Disease primers·2025
Same author

Efficacy of beta-blocker agents on clinical outcomes in patients with thoracic aortic aneurysm: A systematic review and meta-analysis of randomized controlled trials.

Vascular pharmacology·2025

Related Experiment Video

Updated: Feb 17, 2026

Murine Surgical Model of Topical Elastase Induced Descending Thoracic Aortic Aneurysm
08:33

Murine Surgical Model of Topical Elastase Induced Descending Thoracic Aortic Aneurysm

Published on: August 24, 2019

8.1K

Thoracic aortic aneurysm: unlocking the "silent killer" secrets.

Ayman A Saeyeldin1, Camilo A Velasquez1, Syed Usman B Mahmood1

  • 1Aortic Institute at Yale-New Haven, Yale University School of Medicine, 789 Howard Avenue, Clinic Building CB317, P.O. Box 208039, New Haven, CT, USA.

General Thoracic and Cardiovascular Surgery
|December 6, 2017
PubMed
Summary

Thoracic aortic aneurysms (TAA) present diverse origins and risk factors. Current medical treatments show dubious efficacy, emphasizing the need for personalized management strategies based on individual patient profiles.

Keywords:
Aortic dissectionBiomarkersGeneticsIndications for treatmentMedical managementNatural historyThoracic aortic aneurysm

More Related Videos

Ultrasound Imaging of the Thoracic and Abdominal Aorta in Mice to Determine Aneurysm Dimensions
06:08

Ultrasound Imaging of the Thoracic and Abdominal Aorta in Mice to Determine Aneurysm Dimensions

Published on: March 8, 2019

20.8K
Precision Ultrasound-guided Stem Cell Delivery for Vascular Repair in Aortic Diseases
04:59

Precision Ultrasound-guided Stem Cell Delivery for Vascular Repair in Aortic Diseases

Published on: June 20, 2025

823

Related Experiment Videos

Last Updated: Feb 17, 2026

Murine Surgical Model of Topical Elastase Induced Descending Thoracic Aortic Aneurysm
08:33

Murine Surgical Model of Topical Elastase Induced Descending Thoracic Aortic Aneurysm

Published on: August 24, 2019

8.1K
Ultrasound Imaging of the Thoracic and Abdominal Aorta in Mice to Determine Aneurysm Dimensions
06:08

Ultrasound Imaging of the Thoracic and Abdominal Aorta in Mice to Determine Aneurysm Dimensions

Published on: March 8, 2019

20.8K
Precision Ultrasound-guided Stem Cell Delivery for Vascular Repair in Aortic Diseases
04:59

Precision Ultrasound-guided Stem Cell Delivery for Vascular Repair in Aortic Diseases

Published on: June 20, 2025

823

Area of Science:

  • Cardiovascular Medicine
  • Genetics
  • Epidemiology

Background:

  • Thoracic aortic aneurysm (TAA) is increasingly recognized, often found incidentally.
  • Understanding TAA pathogenesis, genetics, and risk factors is crucial for patient outcomes.

Purpose of the Study:

  • To review key epidemiological and clinical aspects of thoracic aortic aneurysms.
  • To highlight differences in pathogenesis, genetics, and risk factors influencing TAA progression and management.

Main Methods:

  • Literature review of ten critical aspects of thoracic aortic aneurysms.
  • Analysis of pathogenesis, familial patterns, sex differences, associated conditions, natural history, diagnostic methods, and treatment options.

Main Results:

  • Ascending and descending TAAs have distinct pathogenesis linked to embryologic origins.
  • Familial patterns and genetics play a role, but syndromic causes are rare (5%).
  • Females experience worse outcomes; TAAs associate with other vascular and inflammatory conditions.
  • Expansion rate and rupture risk depend on familial patterns, location, and size, but size alone is insufficient for risk prediction.
  • Imaging is the primary diagnostic tool; medical treatment efficacy (beta-blockers, ACE inhibitors, ARBs) is uncertain.

Conclusions:

  • TAA management requires a comprehensive approach considering diverse factors beyond size.
  • Further research is needed to clarify the role of medical therapies and develop reliable biomarkers for TAA.
  • Tailored repair strategies and ongoing surveillance are essential for improving TAA patient outcomes.